AC Immune (ACIU) to Release Earnings on Thursday

AC Immune (NASDAQ:ACIU - Get Free Report) will likely be announcing its earnings results before the market opens on Thursday, March 13th. Analysts expect the company to announce earnings of ($0.21) per share and revenue of $0.74 million for the quarter.

AC Immune Price Performance

Shares of ACIU stock traded down $0.08 during trading hours on Friday, reaching $2.41. The stock had a trading volume of 218,752 shares, compared to its average volume of 330,825. AC Immune has a twelve month low of $2.25 and a twelve month high of $4.98. The firm has a 50-day simple moving average of $2.66 and a 200-day simple moving average of $3.01. The firm has a market capitalization of $238.45 million, a PE ratio of -5.24 and a beta of 1.23.

Wall Street Analyst Weigh In

Separately, HC Wainwright reaffirmed a "buy" rating and issued a $16.00 price objective on shares of AC Immune in a report on Friday, November 15th.

About AC Immune

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases.